Sort   by:  
 Page size 
UnknownThe impact of cancer metastases on COVID-19 outcomes: A COVID-19 and Cancer Consortium registry-based retrospective cohort study.
Not available
S-EPMC11141719 | biostudies-literature
UnknownCoinfections in Patients With Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Study.
Not available
S-EPMC8860152 | biostudies-literature
UnknownSystemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Not available
S-EPMC10436185 | biostudies-literature
UnknownCOVID-19 severity and cardiovascular outcomes in SARS-CoV-2-infected patients with cancer and cardiovascular disease.
Not available
S-EPMC10235676 | biostudies-literature
UnknownClinical Characteristics, Racial Inequities, and Outcomes in Patients with Breast Cancer and COVID-19: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Not available
S-EPMC10187350 | biostudies-literature
UnknownClinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: A COVID-19 and cancer consortium (CCC19) cohort study.
Not available
S-EPMC10637772 | biostudies-literature
UnknownVerdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
Not available
S-EPMC11833655 | biostudies-literature
UnknownCNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Not available
S-EPMC11833661 | biostudies-literature
UnknownPridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Not available
S-EPMC11833658 | biostudies-literature
UnknownEfficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Not available
S-EPMC11833520 | biostudies-literature
Sort   by:  
 Page size